Document is current
Any future updates will be listed below
-
Authors
Cross, Benjamin https://orcid.org/0009-0001-8306-7651
Turner, Richard M.
Zhang, J. Eunice https://orcid.org/0000-0003-1813-2207
Pirmohamed, Munir https://orcid.org/0000-0002-7534-7266
- License Information
-
More Information
Article History
Received: 25 July 2023
Revised: 11 February 2024
Accepted: 15 February 2024
First Online: 5 March 2024
Competing interests
: MP receives research funding from various organisations including the MRC, NIHR and EU Commission. He has also received partnership funding for the MRC Clinical Pharmacology Training Scheme (cofunded by MRC and Roche, UCB, Eli Lilly and Novartis). He is member of the Innovative Health Initiative, ARDAT (). RMT is now an employee of GSK; his work on this review started before this employment. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
